These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9874450)

  • 1. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
    Giardina MG; Matarazzo M; Varriale A; Morante R; Napoli A; Martino R
    Cancer; 1992 Sep; 70(5):1044-8. PubMed ID: 1381268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
    Hutchinson WL; Johnson PJ; Du MQ; Williams R
    Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
    López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
    Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
    Shen W; Shen DM
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
    Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
    Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
    Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
    Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
    Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
    Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
    Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
    Yu ZW; Duan FL; Yang XW
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
    Marotta F; Chui DH; Safran P; Zhang SC
    Dig Dis Sci; 1991 Jul; 36(7):993-7. PubMed ID: 1712699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
    El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
    Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
    Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
    Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
    Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
    Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.